Mental Health Intervention for Elderly Abuse Victims (PROTECT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02283385|
Recruitment Status : Recruiting
First Posted : November 5, 2014
Last Update Posted : July 11, 2017
|Condition or disease||Intervention/treatment|
Despite increasing recognition of the epidemic of elder abuse, we continue to face barriers helping abuse victims access and use elder abuse resolution services. In addition, many victims suffer from concurrent mental health problems that prevent them from taking the necessary steps to protect themselves. The proposed study will introduce a tailored intervention, built on an evidence-based approach (Problem Solving Therapy), to be delivered through a sustainable mental health program embedded in elder abuse services. The proposed psychotherapy is a brief 8-session weekly intervention that combines problem-solving therapy, anxiety management, and psycho education developed specifically for this population by this team.
The objectives of the project are to: identify the mental health needs of elder abuse victims, provide the mental health treatment, assess the impact of the treatment, and facilitate conditions which will sustain the mental health program.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||350 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Mental Health Intervention for Elderly Abuse Victims: Providing Options to Elderly Clients Together (PROTECT)|
|Actual Study Start Date :||July 2014|
|Primary Completion Date :||June 30, 2017|
|Estimated Study Completion Date :||December 2017|
Experimental: PROTECT Intervention
Participants will receive a brief psychotherapy that builds on Problem Solving Therapy (PST)
8-session weekly psychotherapy intervention that combines problem-solving therapy, anxiety management and psycho education developed specifically for this population
- Depression (Hamilton Depression Rating Scale) [ Time Frame: 12 weeks ]To document effectiveness of PROTECT intervention in reducing depressive symptoms. Severity of depression will be assessed at baseline and 12 weeks using the Hamilton Depression Rating Scale as the primary measure.
- Functioning (Behavioral Activation for Depression Scale) [ Time Frame: 12 weeks ]To document effectiveness of PROTECT intervention in increasing quality of life, social interaction, and overall functioning. Severity will be assessed at baseline and 12 weeks using the Behavioral Activation for Depression Scale as the primary measure.
- Service Utilization (specialized mistreatment and service outcome questionnaires) [ Time Frame: 12 weeks ]To document effectiveness of PROTECT intervention in increasing clients' utilization of elder abuse services and subsequently reporting a reduction in abuse. Service utilization and severity of abuse will be assessed at baseline and 12 weeks using specialized mistreatment and service outcome questionnaires.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02283385
|Contact: Patrick Raue, PhD||914 997 firstname.lastname@example.org|
|United States, New York|
|Department for the Aging: Elderly Crime Victims Resource Center||Recruiting|
|New York, New York, United States, 10007|
|Contact: Jackie Berman, PhD 212-442-0972 email@example.com|
|Contact: Aurora Salamone, MPS 212 602 4254 firstname.lastname@example.org|
|Principal Investigator: Jackie Berman|
|Jewish Association Serving the Aging||Not yet recruiting|
|New York, New York, United States, 10018|
|Principal Investigator:||Jo Anne Sirey, PhD||Weill Medical College of Cornell University|